Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
I have a surprising reason why: five weeks ago I started taking a new weight-loss drug, Mounjaro. Mounjaro acts in a similar way to Ozempic and Wegovy, but the active substance is different.
Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...
Before using the weight loss drug, the actress shed 80 pounds through ... Ozempic to slim down in time for the “Real Housewives of New Jersey” Season 13 reunion taping.
The new panel of weight loss drugs can help. According to the National Institutes of Health, “Prescription medications to treat overweight and obesity work in different ways. For example ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback